Biotech News
Annexon Biosciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
ir.annexonbio.com2026-05-06 15:01 EST
BRISBANE, Calif., Jan. 07, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at neuroinflammatory diseases that impact nearly 10 million people worldwide, today announced that Douglas Love,